Attovia Therapeutics Inc.
ATTO | NASDAQ
$21.30
-$0.84 (-3.79%)
At close: Sep 21, 2026, 4:00 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 |
|---|---|---|
Cash & Equivalents | 32.83M | 43.3M |
Short-Term Investments | 82.3M | 89.33M |
Long-Term Investments | 404K | 404K |
Other Long-Term Assets | 2.62M | 1.55M |
Receivables | n/a | n/a |
Inventory | n/a | n/a |
Other Current Assets | 3.27M | 4.02M |
Total Current Assets | 118.4M | 136.64M |
Property-Plant & Equipment | 6.92M | 7.49M |
Goodwill & Intangibles | n/a | n/a |
Total Long-Term Assets | 9.95M | 9.44M |
Total Assets | 128.35M | 146.09M |
Account Payables | 6M | 2.56M |
Deferred Revenue | n/a | 450K |
Short-Term Debt | 2.04M | 1.98M |
Other Current Liabilities | 2.67M | 3.52M |
Total Current Liabilities | 12.62M | 9.8M |
Long-Term Debt | n/a | n/a |
Other Long-Term Liabilities | 678K | 750K |
Total Long-Term Liabilities | 2.97M | 3.58M |
Total Liabilities | 15.58M | 13.38M |
Total Debt | 4.33M | 4.8M |
Book Value | 112.77M | 132.71M |
Book Value Per Share | 2.47 | 3.44 |
Common Stock | 1K | 4K |
Retained Earnings | -150.35M | -129.67M |
Comprehensive Income | -79K | -27K |
Shareholders Equity | 112.77M | 132.71M |
Total Investments | 82.71M | 89.73M |
Add to Watchlist
Select watchlists to add or remove ATTO